4.4 Article

The role of the cerebellum in schizophrenia: from cognition to molecular pathways

期刊

CLINICS
卷 66, 期 -, 页码 71-77

出版社

HOSPITAL CLINICAS, UNIV SAO PAULO
DOI: 10.1590/S1807-59322011001300009

关键词

Schizophrenia; Cerebellum; N-methyl D-aspartate receptor; Gamma amino butyric acid; Antipsychotics

资金

  1. European Commission [LSHM-CT-2004-503039]

向作者/读者索取更多资源

Beside its role in motor coordination, the cerebellum is involved in cognitive function such as attention, working memory, verbal learning, and sensory discrimination. In schizophrenia, a disturbed prefronto-thalamo-cerebellar circuit has been proposed to play a role in the pathophysiology. In addition, a deficit in the glutamatergic N-methyl-D-aspartate (NMDA) receptor has been hypothesized. The risk gene neuregulin 1 may play a major role in this process. We demonstrated a higher expression of the NMDA receptor subunit 2D in the right cerebellar regions of schizophrenia patients, which may be a secondary upregulation due to a dysfunctional receptor. In contrast, the neuregulin 1 risk variant containing at least one C-allele was associated with decreased expression of NMDA receptor subunit 2C, leading to a dysfunction of the NMDA receptor, which in turn may lead to a dysfunction of the gamma amino butyric acid (GABA) system. Accordingly, from post-mortem studies, there is accumulating evidence that GABAergic signaling is decreased in the cerebellum of schizophrenia patients. As patients in these studies are treated with antipsychotics long term, we evaluated the effect of long-term haloperidol and clozapine treatment in an animal model. We showed that clozapine may be superior to haloperidol in restoring a deficit in NMDA receptor subunit 2C expression in the cerebellum. We discuss the molecular findings in the light of the role of the cerebellum in attention and cognitive deficits in schizophrenia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease

Nicolai Franzmeier, Jinyi Ren, Alexander Damm, Gemma Monte-Rubio, Merce Boada, Agustin Ruiz, Alfredo Ramirez, Frank Jessen, Emrah Duezel, Octavio Rodriguez Gomez, Tammie Benzinger, Alison Goate, Celeste M. Karch, Anne M. Fagan, Eric McDade, Katharina Buerger, Johannes Levin, Marco Duering, Martin Dichgans, Marc Suarez-Calvet, Christian Haass, Brian A. Gordon, Yen Ying Lim, Colin L. Masters, Daniel Janowitz, Cihan Catak, Steffen Wolfsgruber, Michael Wagner, Esther Milz, Sonia Moreno-Grau, Stefan Teipel, Michel J. Grothe, Ingo Kilimann, Martin Rossor, Nick Fox, Christoph Laske, Jasmeer Chhatwal, Peter Falkai, Robert Perneczky, Jae-Hong Lee, Annika Spottke, Henning Boecker, Frederic Brosseron, Klaus Fliessbach, Michael T. Heneka, Peter Nestor, Oliver Peters, Manuel Fuentes, Felix Menne, Josef Priller, Eike J. Spruth, Christiana Franke, Anja Schneider, Christine Westerteicher, Oliver Speck, Jens Wiltfang, Claudia Bartels, Miguel angel Araque Caballero, Coraline Metzger, Daniel Bittner, Stephen Salloway, Adrian Danek, Jason Hassenstab, Igor Yakushev, Peter R. Schofield, John C. Morris, Randall J. Bateman, Michael Ewers

Summary: The BDNFVal66Met mutation in Alzheimer's disease is associated with a greater impact on cognitive impairment, particularly through a decrease in hippocampal-medial-frontal connectivity. This finding was consistent across ADAD patients and elderly individuals with sporadically occurring Aβ, and was linked to lower global cognitive performance.

MOLECULAR PSYCHIATRY (2021)

Article Psychiatry

Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine

Elias Wagner, William G. Honer, Iris E. Sommer, Sanne Koops, Daniel M. Blumberger, Zafiris J. Daskalakis, Jozarni J. Dlabac-De Lange, Leonie Bais, Henderikus Knegtering, Andre Aleman, Tomas Novak, Monika Klirova, Christina Slotema, Jerome Brunelin, Emmanuel Poulet, Milenko Kujovic, Joachim Cordes, Thomas Wobrock, Dan Siskind, Peter Falkai, Thomas Schneider-Axmann, Alkomiet Hasan

Summary: The study found that rTMS did not show a beneficial effect over sham treatment for patients treated with clozapine, but there may be a possible beneficial effect for improving persistent auditory hallucinations.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

Azmeraw T. Amare, Klaus Oliver Schubert, Liping Hou, Scott R. Clark, Sergi Papiol, Micah Cearns, Urs Heilbronner, Franziska Degenhardt, Fasil Tekola-Ayele, Yi-Hsiang Hsu, Tatyana Shekhtman, Mazda AdIi, Nirmala Akula, Kazufumi Akiyama, Raffaella Ardau, Barbara Arias, Jean-Michel Aubry, Lena Backlund, Kumar Bhattacharjee, Frank Bellivier, Antonio Benabarre, Susanne Bengesser, Joanna M. Biernacka, Armin Birner, Clara Brichant-Petitjean, Pablo Cervantes, Hsi-Chung Chen, Caterina Chillotti, Sven Cichon, Cristiana Cruceanu, Piotr M. Czerski, Nina Dalkner, Alexandre Dayer, Maria Del Zompo, J. Raymond DePaulo, Bruno Etain, Stephane Jamain, Peter Falkai, Andreas J. Forstner, Louise Frisen, Mark A. Frye, Janice M. Fullerton, Sebastien Gard, Julie S. Garnham, Fernando S. Goes, Maria Grigoroiu-Serbanescu, Paul Grof, Ryota Hashimoto, Joanna Hauser, Stefan Herms, Per Hoffmann, Andrea Hofmann, Esther Jimenez, Jean-Pierre Kahn, Layla Kassem, Po-Hsiu Kuo, Tadafumi Kato, John R. Kelsoe, Sarah Kittel-Schneider, Sebastian Kliwicki, Barbara Koenig, Ichiro Kusumi, Gonzalo Laje, Mikael Landen, Catharina Lavebratt, Marion Leboyer, Susan G. Leckband, Alfonso Tortorella, Mirko Manchia, Lina Martinsson, Michael J. McCarthy, Susan L. McElroy, Francesc Colom, Marina Mitjans, Francis M. Mondimore, Palmiero Monteleone, Caroline M. Nievergelt, Markus M. Noethen, Tomas Novak, Claire O'Donovan, Norio Ozaki, Urban Osby, Andrea Pfennig, James B. Potash, Andreas Reif, Eva Reininghaus, Guy A. Rouleau, Janusz K. Rybakowski, Martin Schalling, Peter R. Schofield, Barbara W. Schweizer, Giovanni Severino, Paul D. Shilling, Katzutaka Shimoda, Christian Simhandl, Claire M. Slaney, Alessio Squassina, Thomas Stamm, Pavla Stopkova, Mario Maj, Gustavo Turecki, Eduard Vieta, Julia Veeh, Stephanie H. Witt, Adam Wright, Peter P. Zandi, Philip B. Mitchell, Michael Bauer, Martin Alda, Marcella Rietschel, Francis J. McMahon, Thomas G. Schulze, Bernhard T. Baune

Summary: The study found a significant association between polygenic susceptibility to major depression and response to lithium treatment in patients with bipolar disorder. Patients with a lower polygenic load for depression were more likely to respond well to lithium. This highlights the genetic contribution to lithium response in bipolar disorder and supports the concept of a lithium-responsive biotype.

MOLECULAR PSYCHIATRY (2021)

Article Clinical Neurology

Was King Ludwig II of Bavaria misdiagnosed by Gudden and his colleagues?

Reinhard Steinberg, Peter Falkai

Summary: In 1886, King Ludwig II of Bavaria was diagnosed with paranoia by Bernhard von Gudden and three other expert psychiatrists, leading to his removal from power. The psychiatrists based their diagnosis on sworn eyewitness accounts, general knowledge about Ludwig's behavior, and his extravagance, unusual beliefs, and hallucinations. Despite not evaluating Ludwig in detail, the experts' diagnosis was considered correct in the context of the psychiatric knowledge and societal philosophy of the time.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Article Clinical Neurology

Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial

Isabel Maurus, Alkomiet Hasan, Andrea Schmitt, Astrid Roeh, Daniel Keeser, Berend Malchow, Thomas Schneider-Axmann, Martin Hellmich, Sabine Schmied, Moritz Lembeck, Katriona Keller-Varady, Irina Papazova, Dusan Hirjak, Cristina E. Topor, Henrik Walter, Sebastian Mohnke, Bob O. Vogel, Wolfgang Woelwer, Frank Schneider, Karsten Henkel, Andreas Meyer-Lindenberg, Peter Falkai

Summary: Patients with schizophrenia often have negative symptoms and cognitive deficits, leading to poor outcomes. Aerobic endurance training is believed to have positive effects on various aspects of patients' health. This study aims to investigate the benefits of endurance training on the mental and physical health of patients with schizophrenia.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)

Article Psychiatry

An overview of the human brain myelin proteome and differences associated with schizophrenia

Daniel Martins-de-Souza, Paul C. Guest, Guilherme Reis-de-Oliveira, Andrea Schmitt, Peter Falkai, Christoph W. Turck

Summary: The study characterized the myelin proteome in schizophrenia patients and healthy controls, identifying new proteins associated with myelin. Changes in levels of proteins related to glial cell differentiation, metabolism/energy, synaptic vesicle function and neurodegeneration were observed between the two groups. The findings suggest disruptions in synaptic activity in schizophrenia, with implications for potential drug targets in psychiatric and neurodegenerative disorders.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2021)

Article Substance Abuse

Lower Emotion Regulation Competencies Mediate the Association between Impulsivity and Craving during Alcohol Withdrawal Treatment

Daniela Reichl, Niklas Enewoldsen, Kiona K. Weisel, Sebastian Saur, Lukas Fuhrmann, Catharina Lang, Matthias Berking, Mathias Zink, Andreas Ahnert, Peter Falkai, Thomas Kraus, Thomas Hillemacher, Felix-N Muller, Stephan Lins, Dominikus Bonsch, Linda Kerkemeyer, Sabine Steins-Loeber

Summary: There is evidence that craving mediates the relationship between Impulsive Personality Traits (IPTs) and relapse during the treatment of an Alcohol Use Disorder (AUD). Lower emotion regulation competencies were found to mediate the relationship between attentional as well as non-planning IPTs and craving. These findings contribute to a deeper understanding of the underlying processes and may inform tailored interventions for AUD treatment.

SUBSTANCE USE & MISUSE (2022)

Article Cell Biology

Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte Differentiation

Florian J. Raabe, Marius Stephan, Jan Benedikt Waldeck, Verena Huber, Damianos Demetriou, Nirmal Kannaiyan, Sabrina Galinski, Laura V. Glaser, Michael C. Wehr, Michael J. Ziller, Andrea Schmitt, Peter Falkai, Moritz J. Rossner

Summary: Compared with SOX10 alone, the combination of SON increases the number of induced oligodendrocytes (iOLs) and enhances their complexity and myelin-marker gene expression levels. RNA velocity analysis shows that SOX10 generates OPCs that are apparently more immature than those generated by SON, with distinct molecular properties.
Article Hospitality, Leisure, Sport & Tourism

Exercise addiction measured at a naturalistic marathon-event - associations of the EAI with the general level of functioning, affect And performance parameters

A. Lassner, I Papazova, B. Pross, J. Scherr, J. Schoenfeld, M. Halle, B. Haller, P. Falkai, A. Hasan, A. Roeh

Summary: Endurance sports carry a higher risk of exercise addiction compared to other physical activities. This study evaluated the risk of exercise addiction among amateur marathon runners and investigated its relationship with fitness measures, affect, and general level of functioning.

INTERNATIONAL JOURNAL OF SPORT AND EXERCISE PSYCHOLOGY (2022)

Article Cell Biology

Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study

Andrea Schmitt, Laura Tatsch, Alisa Vollhardt, Thomas Schneider-Axmann, Florian J. Raabe, Lukas Roell, Helmut Heinsen, Patrick R. Hof, Peter Falkai, Christoph Schmitz

Summary: This study utilized stereology to investigate the numbers and densities of different cell types in the brains of individuals with schizophrenia. The results indicated a reduction in oligodendrocytes in the CA4 region in schizophrenia patients, which was absent in the control group.
Review Clinical Neurology

Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors

Andrea Schmitt, Peter Falkai, Sergi Papiol

Summary: Schizophrenia is a neurodevelopmental disorder influenced by genetic and environmental risk factors. The interaction between these factors during prenatal, perinatal, and adolescence periods contribute to the onset of symptoms in early adulthood. These factors lead to disturbances in brain connectivity and molecular/cellular abnormalities.

JOURNAL OF NEURAL TRANSMISSION (2023)

Editorial Material Psychiatry

Innovations in psychiatry: challenges and future directions

Andrea Fiorillo, Antonio Ventriglio, Gaia Sampogna, Peter Falkai

INTERNATIONAL REVIEW OF PSYCHIATRY (2022)

Editorial Material Psychiatry

Publishing Negative Results of Neurobiological Studies in Mental Disorders Will Advance Knowledge in Pathophysiology

Johann Steiner, Andrea Schmitt, Peter Falkai

SCHIZOPHRENIA BULLETIN (2023)

暂无数据